Eli Lilly & Co
LLY· NYSE
Released Jul 28, 2014
10-Q filed Jul 28, 2014, 28 days after period end · 0000059478-14-000129
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q2 2014 | Q2 2013 | Q2 2012 | Q2 2011 |
|---|---|---|---|---|
| Revenue | $4.94B | $5.93B | $5.60B | $6.25B |
| Net Income | $733.50M | $1.21B | $923.60M | $1.20B |
| EPS Diluted | $0.68 |
Eli Lilly & Co · CIK 59478 · Engraved from SEC EDGAR
| $1.11 |
| $0.83 |
| $1.07 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.